Dr. Lal PathLabs Limited Bombay S.E.
Equities
LALPATHLAB
INE600L01024
Healthcare Facilities & Services
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,588 INR | +1.29% | +4.99% | +0.80% |
05-14 | Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 | MT |
05-13 | Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6% | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.47% | 8.01B | |
+67.47% | 4.3B | |
-39.22% | 2.44B | |
-8.65% | 1.89B | |
-17.46% | 1.59B | |
-40.70% | 1.21B | |
+13.38% | 1.17B | |
+15.38% | 966M | |
-7.25% | 925M |
- Stock Market
- Equities
- LALPATHLAB Stock
- LALPATHLAB Stock
- News Dr. Lal PathLabs Limited
- Transcript : Dr. Lal PathLabs Limited, Q2 2022 Earnings Call, Oct 27, 2021